BUB1 and pancreatic ductal adenocarcinoma: As Piao et al. (2019) demonstrated, BUB1 may play a role in the progression of pancreatic ductal adenocarcinoma and could serve as a prognostic biomarker for patients with pancreatic ductal adenocarcinoma.